Hatefi A

References (3)

Title : Stem cell-assisted enzyme\/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands - Li_2023_Med.Oncol_40_110
Author(s) : Li G , Nikkhoi SK , Hatefi A
Ref : Med Oncol , 40 :110 , 2023
Abstract : Li_2023_Med.Oncol_40_110
ESTHER : Li_2023_Med.Oncol_40_110
PubMedSearch : Li_2023_Med.Oncol_40_110
PubMedID: 36862260

Title : Bioengineered adipose-derived stem cells for targeted enzyme-prodrug therapy of ovarian cancer intraperitoneal metastasis - Malekshah_2019_J.Control.Release_311-312_273
Author(s) : Malekshah OM , Sarkar S , Nomani A , Patel N , Javidian P , Goedken M , Polunas M , Louro P , Hatefi A
Ref : J Control Release , 311-312 :273 , 2019
Abstract : Malekshah_2019_J.Control.Release_311-312_273
ESTHER : Malekshah_2019_J.Control.Release_311-312_273
PubMedSearch : Malekshah_2019_J.Control.Release_311-312_273
PubMedID: 31499084

Title : Enzyme\/Prodrug Systems for Cancer Gene Therapy - Malekshah_2016_Curr.Pharmacol.Rep_2_299
Author(s) : Malekshah OM , Chen X , Nomani A , Sarkar S , Hatefi A
Ref : Curr Pharmacol Rep , 2 :299 , 2016
Abstract : Malekshah_2016_Curr.Pharmacol.Rep_2_299
ESTHER : Malekshah_2016_Curr.Pharmacol.Rep_2_299
PubMedSearch : Malekshah_2016_Curr.Pharmacol.Rep_2_299
PubMedID: 28042530